NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization

References

• Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23(11):549–555.12401408
   PubMed Web of Science ®Google Scholar
• Marcus R, Hagenbeek A, The therapeutic use of rituximab in non-Hodgkin‘s lymphoma. Eur J Haematol Suppl. 2007;67:5–14. doi:10.1111/j.1600-0609.2006.00789.x
   PubMedGoogle Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. doi:10.1038/nature0132212490959
   PubMed Web of Science ®Google Scholar
• Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51. doi:10.1016/j.cell.2010.03.01420371344
   PubMed Web of Science ®Google Scholar
• Biswas SK, Sica A, Lewis CE. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol. 2008;180(4):2011–2017.18250403
   PubMed Web of Science ®Google Scholar
• Kakizaki A, Fujimura T, Kambayashi Y, et al. Comparison of CD163+ macrophages and CD206+ cells in lesional skin of CD30+ lymphoproliferative disorders of lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Acta Derm Venereol. 2015;95(5):600–602. doi:10.2340/00015555-201625403560
   PubMed Web of Science ®Google Scholar
• Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172(5):2731–2738.14978070
   PubMed Web of Science ®Google Scholar
• Martinez FO, Helming L, Milde R, et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood. 2013;121(9):e57–69. doi:10.1182/blood-2012-06-43621223293084
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol. 2011;89(4):557–563. doi:10.1189/jlb.071040921248152
   PubMed Web of Science ®Google Scholar
• Jung SH, Hwang JH, Kim SE, Kim YK, Park HC, Lee HT. Human galectin-9 on the porcine cells affects the cytotoxic activity of M1-differentiated THP-1 cells through inducing a shift in M2-differentiated THP-1 cells. Xenotransplantation. 2017;24:4. doi:10.1111/xen.2017.24.issue-4
   Web of Science ®Google Scholar
• Mandal A, Das S, Kumar A, et al. l-Arginine uptake by cationic amino acid transporter promotes intra-macrophage survival of leishmania donovani by enhancing arginase-mediated polyamine synthesis. Front Immunol. 2017;8:839. doi:10.3389/fimmu.2017.0083928798743
   PubMed Web of Science ®Google Scholar
• Gutierrez P, Closa D, Piner R, Bulbena O, Menendez R, Torres A. Macrophage activation in exacerbated COPD with and without community-acquired pneumonia. Eur Respir J. 2010;36(2):285–291. doi:10.1183/09031936.0011890920032016
   PubMed Web of Science ®Google Scholar
• Feng R, Morine Y, Ikemoto T, et al. Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction. Cell Commun Signal. 2018;16(1):54. doi:10.1186/s12964-018-0262-x30180849
   PubMedGoogle Scholar
• Ning Y, Feng W, Cao X, et al. Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis. J Exp Clin Cancer Res. 2019;38(1):19. doi:10.1186/s13046-018-1010-130646963
   PubMedGoogle Scholar
• Estko M, Baumgartner S, Urech K, et al. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro. BMC Complement Altern Med. 2015;15:130. doi:10.1186/s12906-015-0650-325902944
   PubMed Web of Science ®Google Scholar
• Hagemann T, Wilson J, Burke F, et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol. 2006;176(8):5023–5032.16585599
   PubMed Web of Science ®Google Scholar
• Movahedi K, Laoui D, Gysemans C, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010;70(14):5728–5739. doi:10.1158/0008-5472.CAN-09-467220570887
   PubMed Web of Science ®Google Scholar
• Zeng YJ, Lai W, Wu H, et al. Neuroendocrine-like cells-derived CXCL10 and CXCL11 induce the infiltration of tumor-associated macrophage leading to the poor prognosis of colorectal cancer. Oncotarget. 2016;7:27394–27407.27034164
   PubMedGoogle Scholar
• Nam SJ, Go H, Paik JH, et al. An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leuk Lymphoma. 2014;55(11):2466–2476. doi:10.3109/10428194.2013.87971324397616
   PubMed Web of Science ®Google Scholar
• Kridel R, Steidl C, Gascoyne RD. Tumor-associated macrophages in diffuse large B-cell lymphoma. Haematologica. 2015;100(2):143–145. doi:10.3324/haematol.2015.12400825638802
   PubMed Web of Science ®Google Scholar
• Marinaccio C, Ingravallo G, Gaudio F, et al. Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma. Leuk Res. 2014;38(11):1374–1377. doi:10.1016/j.leukres.2014.09.00725293515
   PubMed Web of Science ®Google Scholar
• Isgro MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125–143. doi:10.1007/978-94-017-7215-0_926530364
   PubMed Web of Science ®Google Scholar
• Gonzalez-Quevedo A, Gonzalez-Garcia S, Hernandez-Diaz Z, et al. Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension. J Neurol Sci. 2016;363:158–163. doi:10.1016/j.jns.2016.02.05227000243
   PubMed Web of Science ®Google Scholar
• Massarelli G, Onida GA, Piras MA, Marras V, Mura A, Tanda F. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin‘s disease and large cell lymphomas. Anticancer Res. 1999;19(5B):3933–3938.10628334
   PubMed Web of Science ®Google Scholar
• Wang L, Liu P, Geng Q, Chen X, Lv Y. Prognostic significance of neuron-specific enolase in patients with diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy. Leuk Lymphoma. 2011;52(9):1697–1703. doi:10.3109/10428194.2011.57818721815777
   PubMed Web of Science ®Google Scholar
• Wang L, Liu P, Chen X, Geng Q, Lu Y. Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy. Med Oncol. 2012;29(3):2153–2158. doi:10.1007/s12032-011-0049-z21877195
   PubMed Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329–335. doi:10.1038/nature1575626524530
   PubMed Web of Science ®Google Scholar
• Zhou W, Ke SQ, Huang Z, et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nature Cell Biology. 2015;17(2):170–182. doi:10.1038/ncb309025580734
   PubMed Web of Science ®Google Scholar
• Ying X, Wu Q, Wu X, et al. Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages. Oncotarget. 2016;7(28):43076–43087. doi:10.18632/oncotarget.924627172798
   PubMedGoogle Scholar
• Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12):953–964. doi:10.1038/nri173316322748
   PubMed Web of Science ®Google Scholar
• Saccani A, Schioppa T, Porta C, et al. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 2006;66(23):11432–11440. doi:10.1158/0008-5472.CAN-06-186717145890
   PubMed Web of Science ®Google Scholar
• Sokolova V, Ludwig AK, Hornung S, et al. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B. 2011;87(1):146–150. doi:10.1016/j.colsurfb.2011.05.013
   PubMed Web of Science ®Google Scholar
• Yan T, Skaftnesmo KO, Leiss L, et al. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. BMC Cancer. 2011;11:524. doi:10.1186/1471-2407-11-52422185371
   PubMed Web of Science ®Google Scholar
• Tapia FJ, Polak JM, Barbosa AJ, et al. Neuron-specific enolase is produced by neuroendocrine tumours. Lancet. 1981;1(8224):808–811.6111674
   PubMed Web of Science ®Google Scholar
• Zeng W, Liu P, Pan W, Singh SR, Wei Y. Hypoxia and hypoxia inducible factors in tumor metabolism. Cancer Lett. 2015;356(2 Pt A):263–267. doi:10.1016/j.canlet.2014.01.03224508030
   PubMed Web of Science ®Google Scholar
• Hafner A, Obermajer N, Kos J. gamma-Enolase C-terminal peptide promotes cell survival and neurite outgrowth by activation of the PI3K/Akt and MAPK/ERK signalling pathways. Biochem J. 2012;443(2):439–450. doi:10.1042/BJ2011135122257123
   PubMedGoogle Scholar
• Pislar AH, Kos J. C-terminal peptide of gamma-enolase impairs amyloid-beta-induced apoptosis through p75(NTR) signaling. Neuromol. Med. 2013;15(3):623–635. doi:10.1007/s12017-013-8247-9
   PubMed Web of Science ®Google Scholar
• Hao X, Sun B, Hu L, et al. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004;100(6):1110–1122. doi:10.1002/cncr.2009515022276
   PubMed Web of Science ®Google Scholar
• Ferrigno D, Buccheri G, Giordano C. Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC). Lung Cancer. 2003;41(3):311–320.12928122
   PubMed Web of Science ®Google Scholar
• Soh MA, Garrett SH, Somji S, et al. Arsenic, cadmium and neuron specific enolase (ENO2, gamma-enolase) expression in breast cancer. Cancer Cell Int. 2011;11(1):41. doi:10.1186/1475-2867-11-4122098917
   PubMedGoogle Scholar
• Soh M, Dunlevy JR, Garrett SH, et al. Increased neuron specific enolase expression by urothelial cells exposed to or malignantly transformed by exposure to Cd(2)(+) or As(3)(+). Toxicol Lett. 2012;212(1):66–74. doi:10.1016/j.toxlet.2012.05.00322613180
   PubMed Web of Science ®Google Scholar
• Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin‘s lymphoma. N Engl J Med. 2010;362(10):875–885. doi:10.1056/NEJMoa090568020220182
   PubMed Web of Science ®Google Scholar
• Kridel R, Xerri L, Gelas-Dore B, et al. The prognostic impact of CD163-positive macrophages in follicular lymphoma: a study from the BC cancer agency and the lymphoma study association. Clin Cancer Res. 2015;21(15):3428–3435. doi:10.1158/1078-0432.CCR-14-325325869385
   PubMed Web of Science ®Google Scholar
• Wang H, Li P, Wang L, et al. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type. Ann Hematol. 2015;94(9):1535–1544. doi:10.1007/s00277-015-2401-425990795
   PubMed Web of Science ®Google Scholar
• Caras I, Tucureanu C, Lerescu L, et al. Influence of tumor cell culture supernatants on macrophage functional polarization: in vitro models of macrophage-tumor environment interaction. Tumori. 2011;97(5):647–654. doi:10.1700/989.1072622158498
   PubMed Web of Science ®Google Scholar
• Liao J, Feng W, Wang R, et al. Diverse in vivo effects of soluble and membrane-bound M-CSF on tumor-associated macrophages in lymphoma xenograft model. Oncotarget. 2016;7(2):1354–1366. doi:10.18632/oncotarget.636226595525
   PubMedGoogle Scholar
• Komohara Y, Niino D, Saito Y, et al. Clinical significance of CD163(+) tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma. Cancer Sci. 2013;104(7):945–951. doi:10.1111/cas.1216723557330
   PubMed Web of Science ®Google Scholar
• Bai B, Horlad H, Saito Y, et al. Role of Stat3 activation in cell-cell interaction between B-cell lymphoma and macrophages: the in vitro study. J Clin Exp Hematop. 2013;53(2):127–133.23995109
   PubMedGoogle Scholar
• Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749–759. doi:10.1038/nri170316175180
   PubMed Web of Science ®Google Scholar
• Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25(6):280–288. doi:10.1016/j.it.2004.03.00815145317
   PubMed Web of Science ®Google Scholar
• Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118(3):285–296. doi:10.1016/j.cell.2004.07.01315294155
   PubMed Web of Science ®Google Scholar
• Aung T, Chapuy B, Vogel D, et al. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci U S A. 2011;108(37):15336–15341. doi:10.1073/pnas.110285510821873242
   PubMed Web of Science ®Google Scholar
• Yoon C, Kim J, Park G, et al. Delivery of miR-155 to retinal pigment epithelial cells mediated by Burkitt‘s lymphoma exosomes. Tumour Biol. 2016;37(1):313–321. doi:10.1007/s13277-015-3769-426211004
   PubMedGoogle Scholar